Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes

Overview

This study is designed to compare the effectiveness of LenSx laser arcuate relaxing incisions vs. manual (blade) arcuate relaxing incisions in patients with low, but significant, levels of astigmatism.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 20, 2021

Detailed Description

This study is a comparative, prospective, randomized contralateral eye study of visual outcomes after LenSx laser arcuate relaxing incisions utilizing the Woodcock nomogram at 90% thickness vs. manual (blade) fixed keratome diamond knife at 600 microns for arcuate relaxing incisions utilizing the Donnenfeld nomogram. Subjects will be assessed pre-operatively and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include measurement of visual acuity, manifest refraction and corneal astigmatism measurement with the Lenstar and slit lamp exam.

Interventions

  • Device: femtosecond laser system arcuate corneal incision
    • Corneal arcuate incision made either with a blade (manual) or femtosecond laser system.
  • Other: Manual LRI
    • Manual LRI

Arms, Groups and Cohorts

  • Active Comparator: Femtosecond limbal relaxing incision (LRI)
    • Eyes will be treated with arcuate incisions from a femtosecond laser system.
  • Active Comparator: Manual LRI
    • Eyes will be treated with arcuate incisions completed manually with a blade.

Clinical Trial Outcome Measures

Primary Measures

  • Residual Refractive Astigmatism
    • Time Frame: 3 months
    • Residual refractive astigmatism measured in diopters

Secondary Measures

  • Eyes With Residual Refractive Astigmatism < 0.50 Diopters (D)
    • Time Frame: 3 months
    • The number of eyes with residual refractive astigmatism < 0.50 diopters (D)
  • Uncorrected Monocular Distance Visual Acuity
    • Time Frame: 3 months
    • Uncorrected monocular distance visual acuity in logMAR
  • Spherical Equivalent Refraction
    • Time Frame: 3 months
    • Spherical equivalent refraction in diopters
  • Corneal Astigmatism
    • Time Frame: 3 months
    • Anterior corneal astigmatism

Participating in This Clinical Trial

Inclusion Criteria Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes.

  • are willing and able to understand and sign an informed consent; – are willing and able to attend all study visits; – are more than 40 years of age, of either gender and any race; – are presenting for cataract surgery or refractive lens exchange with a desire to reduce astigmatism and will be implanted with a non-toric lens – have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error and cataract) – have 0.50 D to 1.75 D of regular corneal astigmatism – have potential acuity of 20/25 or better – Are scheduled to have a non-toric monofocal intraocular lens (IOL) (SN60WF) lens implanted in both eyes Exclusion Criteria If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study. – Irregular astigmatism (e.g. keratoconus) – Corneal pathology (e.g. scar, dystrophy, pterygium, moderate-to-severe dry eye) – Monocular status (e.g. amblyopia) – Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g. corneal transplant, lamellar keratoplasty) – Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy) – Diabetic retinopathy – Macular pathology (e.g. age-related macular degeneration, epiretinal membrane) – History of retinal detachment – Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness), that are known to affect post-operative visual acuity. Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Gainesville Eye Associates
  • Collaborator
    • Science in Vision
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Clayton G Blehm, MD, Principal Investigator, Gainesville Eye Associates

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.